Cargando…

Respiratory Viral Infections in Multiple Myeloma Patients

BACKGROUND: Multiple myeloma (MM) patients are at increased risk of respiratory viral infections (RVIs) due to disease-related alterations in their immune systems. Data in the literature specific to MM patients is limited. We reviewed four years of multiplex respiratory viral panel (RVP) data in MM...

Descripción completa

Detalles Bibliográficos
Autores principales: Burgess, Mary J, Mohan, Meera, Crescencio, Juan Carlos Rico, Wolfe, Frankie, Bellamy, William, Kothari, Atul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7107065/
http://dx.doi.org/10.1093/ofid/ofx163.1970
_version_ 1783512737837481984
author Burgess, Mary J
Mohan, Meera
Crescencio, Juan Carlos Rico
Wolfe, Frankie
Bellamy, William
Kothari, Atul
author_facet Burgess, Mary J
Mohan, Meera
Crescencio, Juan Carlos Rico
Wolfe, Frankie
Bellamy, William
Kothari, Atul
author_sort Burgess, Mary J
collection PubMed
description BACKGROUND: Multiple myeloma (MM) patients are at increased risk of respiratory viral infections (RVIs) due to disease-related alterations in their immune systems. Data in the literature specific to MM patients is limited. We reviewed four years of multiplex respiratory viral panel (RVP) data in MM patients at our institution to evaluate incidence and seasonality of RVIs. methods. The results from all positive RVPs, obtained via nasopharyngeal swab and as identified by polymerase chain reaction during the years 2013 to 2016, were analyzed. A positive result less than 6 weeks apart was considered a duplicate and removed. All specimens were analyzed in the molecular diagnostics laboratory using the eSensor® Respiratory Viral Panel (GenMark Dx, Carlsbad, CA). This assay is a qualitative nucleic acid multiplex in vitro diagnostic test that provides for the simultaneous detection and identification of 14 respiratory viral nucleic acids. Results. RVIs were reported in every month in all four years. The peak months were January and February, driven by the peak activity of Influenza and respiratory syncytial virus (RSV). Rhinovirus was isolated the most frequently. The least isolated was Adenovirus. A seasonality was observed with Influenza, RSV, human parainfluenza and human metapneumovirus; however, infections with each virus occurred outside of peak months including an outbreak of Influenza in July and August 2013. The total number of viral infections varied each year as did the total number for each virus. The year 2015 had the lowest number of RVIs reported at 427, followed by the year 2016 with the most RVIs reported at 515. However, 2016 was not the peak incidence for each virus; it was the peak incidence for RSV and Rhinovirus. In fact, Influenza had its lowest number of cases in 2016. Conclusion. At our institution, we have shown that RVIs are more common than previously described in MM patients. RVIs occur in every month throughout the year. Although a seasonality is seen with these viral infections, infections do occur outside of the months considered to be peak months for each virus. Infection control policies, therefore, must be enforced year round. More studies, however, are needed to assess the proportion of community vs. healthcare acquired. Two DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-7107065
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-71070652020-04-02 Respiratory Viral Infections in Multiple Myeloma Patients Burgess, Mary J Mohan, Meera Crescencio, Juan Carlos Rico Wolfe, Frankie Bellamy, William Kothari, Atul Open Forum Infect Dis Abstracts BACKGROUND: Multiple myeloma (MM) patients are at increased risk of respiratory viral infections (RVIs) due to disease-related alterations in their immune systems. Data in the literature specific to MM patients is limited. We reviewed four years of multiplex respiratory viral panel (RVP) data in MM patients at our institution to evaluate incidence and seasonality of RVIs. methods. The results from all positive RVPs, obtained via nasopharyngeal swab and as identified by polymerase chain reaction during the years 2013 to 2016, were analyzed. A positive result less than 6 weeks apart was considered a duplicate and removed. All specimens were analyzed in the molecular diagnostics laboratory using the eSensor® Respiratory Viral Panel (GenMark Dx, Carlsbad, CA). This assay is a qualitative nucleic acid multiplex in vitro diagnostic test that provides for the simultaneous detection and identification of 14 respiratory viral nucleic acids. Results. RVIs were reported in every month in all four years. The peak months were January and February, driven by the peak activity of Influenza and respiratory syncytial virus (RSV). Rhinovirus was isolated the most frequently. The least isolated was Adenovirus. A seasonality was observed with Influenza, RSV, human parainfluenza and human metapneumovirus; however, infections with each virus occurred outside of peak months including an outbreak of Influenza in July and August 2013. The total number of viral infections varied each year as did the total number for each virus. The year 2015 had the lowest number of RVIs reported at 427, followed by the year 2016 with the most RVIs reported at 515. However, 2016 was not the peak incidence for each virus; it was the peak incidence for RSV and Rhinovirus. In fact, Influenza had its lowest number of cases in 2016. Conclusion. At our institution, we have shown that RVIs are more common than previously described in MM patients. RVIs occur in every month throughout the year. Although a seasonality is seen with these viral infections, infections do occur outside of the months considered to be peak months for each virus. Infection control policies, therefore, must be enforced year round. More studies, however, are needed to assess the proportion of community vs. healthcare acquired. Two DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2017-10-04 /pmc/articles/PMC7107065/ http://dx.doi.org/10.1093/ofid/ofx163.1970 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Burgess, Mary J
Mohan, Meera
Crescencio, Juan Carlos Rico
Wolfe, Frankie
Bellamy, William
Kothari, Atul
Respiratory Viral Infections in Multiple Myeloma Patients
title Respiratory Viral Infections in Multiple Myeloma Patients
title_full Respiratory Viral Infections in Multiple Myeloma Patients
title_fullStr Respiratory Viral Infections in Multiple Myeloma Patients
title_full_unstemmed Respiratory Viral Infections in Multiple Myeloma Patients
title_short Respiratory Viral Infections in Multiple Myeloma Patients
title_sort respiratory viral infections in multiple myeloma patients
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7107065/
http://dx.doi.org/10.1093/ofid/ofx163.1970
work_keys_str_mv AT burgessmaryj respiratoryviralinfectionsinmultiplemyelomapatients
AT mohanmeera respiratoryviralinfectionsinmultiplemyelomapatients
AT crescenciojuancarlosrico respiratoryviralinfectionsinmultiplemyelomapatients
AT wolfefrankie respiratoryviralinfectionsinmultiplemyelomapatients
AT bellamywilliam respiratoryviralinfectionsinmultiplemyelomapatients
AT kothariatul respiratoryviralinfectionsinmultiplemyelomapatients